First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors
Publication Date
2024
Content Type
Article
PubMed ID:
Citation
Cancer Research Communications (2024) 4(4):1100-1110